High Relapse Risk in Diabetic Foot Ulcers
Summary: A Medscape view article published in 2025 highlights striking new data showing that diabetic foot ulcers (DFUs) carry relapse risks at levels that match or exceed those of aggressive cancers. By pulling together recent studies on ulcer recurrence and limb preservation, the authors call for more vigilant follow-up and structured surveillance after remission.
Key Highlights:
- At 3 years after healing (remission), approximately **58%** of patients with DFUs experience recurrence.
- Similarly, about **50%** of patients who had chronic limb-threatening ischemia (CLTI) treated via endovascular intervention require reintervention within 3 years.
- Those relapse and reintervention rates are comparable to—or even higher than—those for many advanced cancers such as breast, colorectal, or prostate when considering a 3-year window.
- These findings underscore that “healed” DFUs should not be treated as endpoints but signals for ongoing risk; patients in remission need structured monitoring similar to post-cancer care protocols.
Read the full article on Medscape
Keywords:
diabetic foot ulcer recurrence,
chronic limb-threatening ischemia (CLTI),
relapse risk,
three-year rate